| Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants M Yuan, D Huang, CCD Lee, NC Wu, AM Jackson, X Zhu, H Liu, L Peng, ... Science 373 (6556), 818-823, 2021 | 371 | 2021 |
| A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model J Kreye, SM Reincke, HC Kornau, E Sánchez-Sendin, VM Corman, H Liu, ... Cell 183 (4), 1058-1069. e19, 2020 | 352 | 2020 |
| High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms C Franke, C Ferse, J Kreye, SM Reincke, E Sanchez-Sendin, A Rocco, ... Brain, behavior, and immunity 93, 415-419, 2021 | 272 | 2021 |
| Subunit composition of VRAC channels determines substrate specificity and cellular resistance to P t‐based anti‐cancer drugs R Planells‐Cases, D Lutter, C Guyader, NM Gerhards, F Ullrich, DA Elger, ... The EMBO journal 34 (24), 2993-3008, 2015 | 252 | 2015 |
| SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies SM Reincke, M Yuan, HC Kornau, VM Corman, S van Hoof, ... Science 375 (6582), 782-787, 2022 | 78 | 2022 |
| Do cross-reactive antibodies cause neuropathology in COVID-19? J Kreye, SM Reincke, H Prüss Nature Reviews Immunology 20 (11), 645-646, 2020 | 69 | 2020 |
| Inactivation and anion selectivity of volume-regulated anion channels (VRACs) depend on C-terminal residues of the first extracellular loop F Ullrich, SM Reincke, FK Voss, T Stauber, TJ Jentsch Journal of Biological Chemistry 291 (33), 17040-17048, 2016 | 63 | 2016 |
| Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis F Scheibe, L Ostendorf, SM Reincke, H Prüss, AC Von Bruenneck, ... Journal of neurology 267, 317-323, 2020 | 61 | 2020 |
| A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection H Liu, M Yuan, D Huang, S Bangaru, F Zhao, CCD Lee, L Peng, ... Cell host & microbe 29 (5), 806-818. e6, 2021 | 59 | 2021 |
| N‐methyl‐D‐aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit NK Wenke, J Kreye, E Andrzejak, A van Casteren, J Leubner, ... Annals of neurology 85 (5), 771-776, 2019 | 58 | 2019 |
| Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells SM Reincke, N von Wardenburg, MA Homeyer, HC Kornau, G Spagni, ... Cell 186 (23), 5084-5097. e18, 2023 | 57 | 2023 |
| Encephalitis patient-derived monoclonal GABAA receptor antibodies cause epileptic seizures J Kreye, SK Wright, A van Casteren, L Stöffler, ML Machule, SM Reincke, ... Journal of Experimental Medicine 218 (11), e20210012, 2021 | 48 | 2021 |
| Affinities of human NMDA receptor autoantibodies: implications for disease mechanisms and clinical diagnostics LT Ly, J Kreye, B Jurek, J Leubner, F Scheibe, J Lemcke, NK Wenke, ... Journal of Neurology 265 (11), 2625-2632, 2018 | 43 | 2018 |
| Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics E Wyler, JM Adler, K Eschke, GT Alves, S Peidli, F Pott, J Kazmierski, ... Molecular Therapy 30 (5), 1952-1965, 2022 | 33 | 2022 |
| Brain antibody sequence evaluation (BASE): an easy-to-use software for complete data analysis in single cell immunoglobulin cloning SM Reincke, H Prüss, J Kreye BMC bioinformatics 21, 1-10, 2020 | 11 | 2020 |
| Cross-regulation of antibody responses against the SARS-CoV-2 spike protein and commensal microbiota via molecular mimicry M Bondareva, L Budzinski, P Durek, M Witkowski, S Angermair, ... Cell Host & Microbe 31 (11), 1866-1881. e10, 2023 | 8 | 2023 |
| Brain blood vessel autoantibodies in patients with NMDA and GABAA receptor encephalitis: identification of unconventional Myosin-X as target antigen LY Li, J Kreye, M Burek, C Cordero-Gomez, PC Barthel, ... Frontiers in Cellular Neuroscience 17, 1077204, 2023 | 7 | 2023 |
| Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy S Huo, C Ferse, F Bösl, SM Reincke, P Enghard, C Hinrichs, S Treskatsch, ... Journal of Neurology 269 (8), 4013-4020, 2022 | 7 | 2022 |
| Antigenic imprinting in SARS‐CoV‐2 SM Reincke, H Prüss, IA Wilson, J Kreye Clinical and translational medicine 12 (7), 2022 | 7 | 2022 |
| Induction of cross-reactive antibody responses against the RBD domain of the spike protein of SARS-CoV-2 by commensal microbiota J Ninnemann, L Budzinski, M Bondareva, M Witkowski, S Angermair, ... Biorxiv, 2021.08. 08.455272, 2021 | 7 | 2021 |
